Literature DB >> 30808507

Epidural analgesia? A prospective analysis of perioperative coagulation in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Desiree A Teoh1, Meredith J H Hutton2, Scott Else2, Andrew Walker2, Adrienne Lee3, Lloyd A Mack4.   

Abstract

BACKGROUND: Cytoreductive surgery (CRS) and heated intraperitoneal chemotherapy (HIPEC) is beneficial in peritoneal carcinomatosis. Epidurals provide excellent pain relief for laparotomies. Coagulopathy (platelet count <100 × 109/L, INR>1.5 or PTT >45) occurs with CRS and HIPEC, increasing risk for bleeding complications with epidurals. This prospective study characterizes clot kinetics with thromboelastography (TEG) to determine suitability for epidural analgesia.
METHODS: After Research Ethics approval, thirty consented patients had blood collected. Primary data collected included TEG and conventional coagulation measures (platelets, PTT and INR). Secondary data collected included demographics, disease, surgical, intraoperative factors and complications from epidural placement.
RESULTS: Of 30 patients analyzed, two had incomplete data. Four developed abnormal coagulation between the second and fifth post-operative day. For all patients, TEG values remained normal. Postoperative INR was elevated until day 3 (all INR < 1.5). 17 patients received epidural analgesia, 3 demonstrated abnormal conventional coagulopathic criteria despite normal TEG.
CONCLUSIONS: In this study CRS and HIPEC do not contribute to the conventional definition of clinical coagulopathy. Clot kinetics indicate that epidural catheters may be recommended for post-operative analgesia. Crown
Copyright © 2019. Published by Elsevier Inc. All rights reserved.

Entities:  

Year:  2019        PMID: 30808507     DOI: 10.1016/j.amjsurg.2019.01.034

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  4 in total

1.  HIPEC as a risk factor for postoperative coagulopathy after cytoreductive surgery for peritoneal metastases.

Authors:  Antonio Sommariva; Marco Tonello; Emanuele Migliori; Elisa Pizzolato; Carola Cenzi; Marica Mirabella; Pierluigi Pilati
Journal:  Updates Surg       Date:  2022-08-06

2.  Society of Onco-Anaesthesia and Perioperative Care consensus guidelines for perioperative management of patients for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC).

Authors:  Sohan Lal Solanki; Sudipta Mukherjee; Vandana Agarwal; Raghu S Thota; Kalpana Balakrishnan; Shagun Bhatia Shah; Neha Desai; Rakesh Garg; Reshma P Ambulkar; Nitin Madhukar Bhorkar; Viplab Patro; Snita Sinukumar; Meenakshi V Venketeswaran; Malini P Joshi; Rajesh Holalu Chikkalingegowda; Vijaya Gottumukkala; Pascal Owusu-Agyemang; Avanish P Saklani; Sanket Sharad Mehta; Ramakrishnan Ayloor Seshadri; John C Bell; Sushma Bhatnagar; Jigeeshu V Divatia
Journal:  Indian J Anaesth       Date:  2019-12-11

3.  Thromboelastography-guided blood transfusion during cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy: study protocol for a prospective randomised controlled trial.

Authors:  Shaoheng Wang; Qing Zhang; Linfeng Chen; Gang Liu; Peng Fei Liu
Journal:  BMJ Open       Date:  2020-11-12       Impact factor: 2.692

4.  The impact of ultrasound-guided bilateral rectus sheath block in patients undergoing cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy - a retrospective study.

Authors:  Shaoheng Wang; Pengfei Liu; Teng Gao; Lei Guan; Tianzuo Li
Journal:  BMC Anesthesiol       Date:  2020-08-11       Impact factor: 2.217

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.